Bill Maher is Director of TEKLA LIFE SCIENCES INVESTORS. Currently has a direct ownership of 1,000 shares of HQL, which is worth approximately $13,790. The most recent transaction as insider was on Dec 28, 2023, when has been sold 1,000 shares (Common Stock) at a price of $13.57 per share, resulting in proceeds of $13,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
0% 3M change
n/a 12M change
Total Value Held $13,790

Bill Maher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2023
BUY
Open market or private purchase
$13,570 $13.57 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

HQH
TEKLA HEALTHCARE INVESTORS Financial Services
THQ
Tekla Healthcare Opportunities Fund Financial Services
THW
Tekla World Healthcare Fund Financial Services
AEF
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. Financial Services
JEQ
ABERDEEN JAPAN EQUITY FUND, INC. Financial Services
VFL
Delaware Investments National Municipal Income Fund Financial Services
BM

Bill Maher

Director
Phildadelphia, PA

Track Institutional and Insider Activities on HQL

Follow TEKLA LIFE SCIENCES INVESTORS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HQL shares.

Notify only if

Insider Trading

Get notified when an Tekla Life Sciences Investors insider buys or sells HQL shares.

Notify only if

News

Receive news related to TEKLA LIFE SCIENCES INVESTORS

Track Activities on HQL